Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
Phase 1/2 Terminated
8 enrolled 13 charts
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
Phase 1/2 Terminated
19 enrolled 11 charts
ALAFOSS-01
Phase 1 Terminated
17 enrolled
CONCORDE
Phase NA Terminated
21 enrolled
Ascorbate With Durvalumab in Non-Small Cell Lung Cancer (NSCLC)
Phase 1 Terminated
1 enrolled
Study of Vudalimab or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced NSCLC
Phase 1/2 Terminated
28 enrolled
A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer
Phase 2 Terminated
50 enrolled 18 charts
Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients
Phase 1/2 Terminated
59 enrolled
AcceleRET-Lung
Phase 3 Terminated
223 enrolled 18 charts
Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway
Phase 1 Terminated
29 enrolled
OPTIMUNELUNG
Phase 2 Terminated
8 enrolled
Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
Phase 1 Terminated
12 enrolled
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
Phase 1/2 Terminated
13 enrolled
An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer
Phase NA Terminated
1 enrolled
PRO1107 in Patients With Advanced Solid Tumors
Phase 1/2 Terminated
33 enrolled
A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.
Phase 1 Terminated
10 enrolled
Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC
Phase 2 Terminated
93 enrolled
Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer
Phase 2 Terminated
14 enrolled 16 charts
PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors
Phase 1 Terminated
21 enrolled
A Phase 1 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway
Phase 1 Terminated
64 enrolled
Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer
Phase 2 Terminated
6 enrolled 3 charts
A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors
Phase 1 Terminated
30 enrolled
Culturally Tailored Educational Video to Promote Lung Cancer Screening in Vulnerable Communities
Phase NA Terminated
11 enrolled
Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer
Phase 1/2 Terminated
25 enrolled 11 charts
Tamarack
Phase 2 Terminated
192 enrolled 20 charts
Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC Regimen
Phase 1 Terminated
4 enrolled
Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC
Phase 1 Terminated
16 enrolled 9 charts
MESO-PRIME
Phase 1 Terminated
5 enrolled 13 charts
Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease
Phase 1 Terminated
5 enrolled
Microwave Ablation in Chinese Patients With Lung Tumors
Phase NA Terminated
13 enrolled 11 charts
A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation
Phase 1 Terminated
42 enrolled
SHAREDCare
Phase NA Terminated
5 enrolled
PRIMING
Phase 1 Terminated
2 enrolled 10 charts
Oncomabs
Terminated
80 enrolled
A Study of PHN-010 in Patients With Advanced Solid Tumors
Phase 1 Terminated
26 enrolled
TRIPLEX
Phase 3 Terminated
239 enrolled
EPITOP-01
Phase 4 Terminated
40 enrolled
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Phase 1/2 Terminated
61 enrolled 29 charts
Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases
Phase 2 Terminated
3 enrolled 12 charts
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Phase 1 Terminated
79 enrolled 24 charts
Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI
Phase 1 Terminated
9 enrolled
This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091
Phase 1 Terminated
8 enrolled 10 charts
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Phase 1/2 Terminated
73 enrolled
Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)
Phase 1/2 Terminated
34 enrolled 44 charts
A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors
Phase 1 Terminated
250 enrolled
A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma
Phase 2 Terminated
19 enrolled 12 charts
Biomarkers of Response to Ipilimumab and Nivolumab in First-line NSCLC
Phase 2 Terminated
5 enrolled 13 charts
ATLAS
Phase 2 Terminated
5 enrolled
HBI-8000
Phase 2 Terminated
5 enrolled 8 charts
BRIDGE
Phase 2 Terminated
10 enrolled